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Brucellosis is a disease involving the lymphoproliferative
system, which may lead to changes in the hematological
parameters; however, pancytopenia is a rare finding. However,
malignant diseases in association with brucellosis are rarely the
cause of pancytopenia. Herein, two cases with fever and
pancytopenia, diagnosed as simultaneous acute lymphoblastic
leukemia and brucellosis are presented. Anti-leukemic therapy
and brucellosis treatment were administered simultaneously,
and normal blood parameters obtained. The first patient is in
complete remission; the other recovered from the brucellosis,
but later died due to a leukemic relapse.
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INTRODUCTION
Brucellosis is an infectious disease involving the
lymphoproliferative system. Changes in the
hematological parameters are observed in most
patients, but pancytopenia is rare.
1,2 Hemophago-
cytosis, hypersplenism or granulomatous changes
in the bone marrow may be responsible for pancy-
topenia occurring during brucellosis.
1,2 Addition-
ally, bone marrow involvement due to the simul-
taneous presentation of malignant diseases with
brucellosis rarely lead to pancytopenia. Herein,
two cases with fever and pancytopenia, diagnosed
as simultaneous acute lymphoblastic leukemia
(ALL) and brucellosis are presented with the
associated literature data.
CASE REPORT
Case I
A 39-year-old female presented with a one
month history of weakness, headache, nausea,
vomiting and fever. A physical examination re-
vealed significant pallor, fever (axillary's measure-
ment: 39 ) and tachycardia (pulse rate: 100/
min). A high erythrocyte sedimentation rate (120
mm/hr), pancytopenia in complete blood count
(Hb: 6.0 g/dL, platelet: 34 × 10
9/L, WBC: 1.1 ×
10
9/ L with 80% lymphocyte, 10% atypical mono-
nuclear cells, 10% neutrophil) was detected in a
laboratory examination. The serum biochemistry
parameters were within normal ranges; BUN: 24
mg/dL, creatinine: 1.2 mg/dL, urate: 6.6 mg/dL,
alanine transaminase: 22 U/L, aspartate trans-
aminase: 31 U/L and lactic dehydrogenase: 185
U/L. Bone marrow aspiration and trephine biopsy
histologically consisted of ALL (90% of the nu-
cleated cells of bone marrow were lymphoblasts
which were T cell immuno-histochemical markers)
(Fig. 1, 2). A chemotherapy regimen, consisting of
adriamycine (50 mg/week/total two doses), vin-
cristine (2 mg/week/total two doses) and predni-
sone (100 mg/day/p.o./for 14 days), was started.
Brucella melitensis was detected in a bone mar-
row culture, so a brucellosis treatment (strepto-
mycin 1 g/day/intramuscularly, doxycycline 100
mg/bid/p.o.) was added. Her temperature re-
turned to normal within three weeks, and the
complete blood count and bone marrow findings
Acute Lymphoblastic Leukemia Associated with Brucellosis
in Two Patients with Fever and Pancytopenia
Bulent Eser,
1 Fevzi Altuntas,
1 Isin Soyuer,
2 Ozlem Er,
1 Ozlem Canoz,
2 Hasan Senol Coskun,
1 Mustafa Cetin,
1
and Ali Unal
1
Departments of
1Hematology-Oncology,
2Pathology, Erciyes University School of Medicine, Kayseri, Turkey.
Received July 11, 2003
Accepted January 15, 2004
Reprint address: requests to Dr. Bulent Eser, Department of
Hematology-Oncology, Dedeman Oncology Hospital, Erciyes
University School of Medicine, 38039, Kayseri, Turkey. Tel, Fax:
90-352-4379348, E-mail: beser@erciyes.edu.trBulent Eser, et al.
Yonsei Med J Vol. 47, No. 5, 2006
also returned to normal (Hb: 12 g/dL, platelet: 180
× 10
9/L, WBC: 4.5 × 10
9/L, with 70% neutrophil,
25% lymphocyte and 5% monocyte, a bone mar-
row aspirate was normocellular and the blasts
content was less than 1% of the nucleated cells).
The patient received brucellosis treatment for six
weeks. Repeat blood and bone marrow cultures
and an agglutination test were negative. The
patient is in complete remission from ALL, and
the follow up continuing.
Case II
A 40-year-old female presented with a 20 day
history of fever, weakness, headache and weight
loss and a one week history of jaundice. On
admission she was febrile (axillary's measure-
ment: 38.5 ), pancytopenic (Hb: 7g/dL, platelet:
20×10
9/L, WBC: 0.5×10
9/L, with 90% lympho-
cyte and 10% neutrophil) and demonstrated acute
hepatitis (AST: 250 U/L, ALT: 320 U/L, direct
bilirubin: 12 mg/dL, indirect bilirubin: 8 mg/dL,
LDH: 450 U/L). A bone marrow aspiration his-
tologically consisted of ALL (90% of the nucleated
cells of bone marrow were lymphoblasts, which
were T cell immuno-histochemical stained). The
blood and bone marrow cultures were positive for
Brucella melitensis. Because the liver function tests
were abnormal, i.v. ciprofloxacin was started at
100 mg twice a day. In addition to this treatment
prednisone (100 mg/day/p.o.) and vincristine (2
mg/ day/once in a week for three doses) were
used for ALL. Her temperature was normal on the
14th day, and the clinical and laboratory findings
were nearly normal (Hb: 11 g/dL, platelet count:
90×10
9/L, WBC: 3.2 × 10
9/L, with 75% neutro-
phil, 23% lymphocyte, 2% monocyte, AST: 72
U/L, ALT: 83 U/L, direct bilirubin: 2.1 mg/dL,
indirect bilirubin: 1.2 mg/dL, LDH: 450 U/L). The
leukemic infiltration disappeared in a bone mar-
row biopsy (blasts < 1%) and a liver biopsy re-
vealed findings of granulomatous hepatitis (Fig.
3). Twenty days later she presented again with
fever, jaundice and pancytopenia. A bone marrow
biopsy showed 90% lymphoblasts. The blood and
bone marrow cultures were negative for brucella,
and a brucella agglutination test was negative.
The ALL Hoelzer remission induction protocol
was administered to the patient, and complete
Fig. 1. The predominating cells are lymphoblasts; these
cells possess round, oval or indented nuclei containing
coarse granular chromatin (My-Grunwald-Giemsa × 1000).
Fig. 2. Intensive lymphoblastic cells in the paratrabecular
area (Hematoxylin-eosin × 400).
Fig. 3. Granulomatous structure, consisting of epitheloid
histiocytes in the liver section (Hematoxylin-eosin × 200).ALL Associated with Brucellosis
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remission obtained. Two months later, a relapse
occurred during the administration of consoli-
dation treatment. Although re-induction treatment
was given, she died due to resistant leukemia.
DISCUSSION
Brucella species are gram-negative, coccoba-
cillary, non-motile and facultative aerobic, intra-
cellular microorganisms. The main sources of
Brucella are infected animals or their products,
such as milk, cream, butter, fresh cheese, ice
cream, urine, blood, carcasses and abortion pro-
ducts. Brucellosis is a systemic disease that may
involve any organ or tissue. The most common
symptoms of brucellosis are fever, sweats, mal-
aise, anorexia, arthralgia and back pain.
3,4 The
majority of these symptoms, including fever,
sweats and malaise, were also observed in our
patients.
Serological tests (Wright agglutination test
above 1/160 titers) are helpful in the diagnosis,
but the accurate diagnosis is based on the posi-
tivity of blood or bone marrow cultures. Anemia
is the most frequently observed hematological
abnormality in brucellosis, with leukopenia and
thrombocytopenia less frequently observed.
1,2,5
Pancytopenia is reported in 5.8 to 14% of cases.
1,2,6
In brucellosis, patients with pancytopenia gener-
ally show hypercellularity on bone marrow
examination.
7,8 Hemophagocytosis is thought to
be primarily responsible for the pancytopenia, but
granulomatous lesion formation in the bone
marrow or hypersplenism may also play a role.
7,8
Bone marrow and other hematological abnor-
malities generally revert to normal within 2 - 3
weeks of therapy.
1,6 We saw hypercellularity and
infiltration, with lymphoblastic cells, in bone
marrow examinations of our cases. Neither hemo-
phagocytosis nor granulomatous lesions were
present. Leukemic infiltration of the bone marrow
was thought to be responsible for the pancytope-
nia in these patients. Anti-leukemic therapy and
brucellosis treatment were administered simulta-
neously, and normal blood parameters obtained
within three weeks. One of the patients is in
complete remission; the other recovered from the
brucellosis, but later died because of an ALL
relapse.
Hepatocellular carcinoma
9, multiple myeloma,
10
Hodgkin's disease,
11 sinus histiocytosis, with mas-
sive lymphadenopathy,
12 and hairy cell leukemia
13
in association with brucellosis have been reported
in the literature. Immunity to brucellosis is espe-
cially dependent on CD 8 positive T cells and the
T cell mediated activation of macrophages.
14,15 For
this reason an organism is more susceptible to
brucellosis when the cellular immunity is defec-
tive. The development of brucellosis may have
resulted from a cellular immunity defect in our
cases. The incidence of ALL is approximately
1/100,000, 25% of these are of T cell origin. A
genetic predisposition, radiation, chemotherapy
and viral infections (Epstein-Barr virus, HTLV-I
virus) may play roles in the etio-pathogenesis. The
relationship between brucellosis and acute lym-
phoblastic leukemia is extremely rare, even in the
regions where brucellosis is endemic.
16 Brucella
infection was not shown to play a role in leukemic
development in humans. However, the increase in
the absolute number of splenic cells in mice
infected with the Rauscher leukemia virus and
brucella was initially caused by the lymphoid
tissue reaction to brucella rather than by the
development of leukemia in mice.
17 It is difficult
to distinguish the simultaneous occurrence of ALL
and brucellosis from the facilitatory effects of
other or coincidental events.
The true incidence of human brucellosis is
unknown. The World Health Organization (WHO)
points out that 500,000 cases of brucellosis are
reported each year from around the world.
Turkey is also an endemic country for brucellosis.
In 1999, 11,462 cases were notified to the Ministry
of Health, with an incidence rate of 17.4/100,000.
In a multicenter seroprevalence study in Turkey,
the seropositivity rate was found to be 1.8% in the
healthy population and 6% in the high-risk
occupational groups (veterinarians, workers in
abattoirs and butchers, etc.).
18
When we consider the hematological findings
and treatment results in our patients, the dif-
ferential diagnosis should include brucellosis in
patients presenting with fever and pancytopenia,
especially in regions where brucellosis is endemic.
Pancytopenia, observed in association with brucel-
losis, may be caused by the infection itself or byBulent Eser, et al.
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bone marrow infiltration of malignant disease. In
addition, hematologic guidelines recommend a
bone marrow trephine biopsy be performed in
patients with unexplained cytopenia.
19,20 For this
reason, a bone marrow aspiration or biopsy
should be considered both for the determination
of the cause of pancytopenia and to eliminate any
other disease that may be a cause of pancytopenia,
even if brucellosis is accurately diagnosed in these
patients. In patients with brucellosis and acute
leukemia we suggest that simultaneous treatment
for infection and leukemia is the best choice to
decrease the morbidity and mortality.
REFERENCES
1. Akdeniz H, Irmak H, Seckinli T, Buzgan T, Demiroz
AP. Hematological manifestations in brucellosis cases
in Turkey. Acta Med Okayama 1998;52:63-5.
2. al-Eissa Y, al-Nasser M. Hematological manifestations
of childhood brucellosis. Infection 1993;21:23-6.
3. Aygen B, Doğanay M, Su ¨merkan B, Yildiz O, Kayabas ¸
U. Clinical manifestations, complications and treatment
of brucellosis: a retrospective evaluation of 480 patients.
Me ´d Mal Infect 2002;32:485-93.
4. Young EJ. Brucella species. In: Mandell GL, Bennett JE,
Dolin R, editors. Principles and practice of infectious
diseases, Vol. 2. Philadelphia: Churchill Livingstone;
2000. p.2386-92.
5. Galanakis E, Bourantas KL, Leveidiotou S, Lapatsanis
PD. Childhood brucellosis in north-western Greece: a
retrospective analysis. Eur J Pediatr 1996;155:1-6.
6. al-Eissa YA, Assuhaimi SA, al-Fawaz IM, Higgy KE,
al-Nasser MN, al-Mobaireek KF. Pancytopenia in
children with brucellosis: clinical manifestations and
bone marrow findings. Acta Haematol 1993;89:132-6.
7. Martin-Moreno S, Soto-Guzman O, Bernaldo-de-Quiros
J, Reverte-Cejudo D, Bascones-Casas C. Pancytopenia
due to hemophagocytosis in patients with brucellosis:
a report of four cases. J Infect Dis 1983;147:445-9.
8. Garcia P, Yrivarren JL, Argumans C, Crosby E, Carrillo
C, Gotuzzo E. Evaluation of the bone marrow in
patients with brucellosis. Clinico-pathological correla-
tion. Enferm Infecc Microbiol Clin 1990;8:19-24.
9. Barutca S, Sivri B. Brucellosis and hepatocellular
carcinoma: just a coincidence? Am J Gastroenterol 1998;
93:854-5.
10. Lopez L, del Villar V, Bergua J. Fever caused by
myeloma or brucellosis? Overlapping of two entities.
Sangre (Barc) 1995;40:165-6.
11. Stempien R, Bergiel A. Chronic brucellosis and
Hodgkin's disease. Wiad Lek 1968;21:1819-21.
12. Yao JD, McCullough AE, Walker RC, Banks PM.
Brucellosis and sinus histiocytosis with massive
lymphadenopathy. Am J Med 1989;86:111-4.
13. Oksenhendler E, Moriniere B, Rouveix E. Brucellosis in
hairy cell leukaemia. Trans R Soc Trop Med Hyg 1988;
82:336.
14. Oliveira SC, Harms JS, Rech EL, Rodarte RS, Bocca AL,
Goes AM, et al. The role of T cell subsets and cytokines
in the regulation of intracellular bacterial infection.
Braz J Med Biol Res 1998;31:77-84.
15. Splitter G, Oliveira S, Carey M, Miller C, Ko J, Covert
J. T lymphocyte mediated protection against facultative
intracellular bacteria. Vet Immunol Immunopathol
1996;54:309-19.
16. Ozcay F, Derbent M, Ergin F, Duru F, Ozbek N. Febrile
neutropenia caused by Brucella melitensis in a child
with hypoplastic acute lymphoblastic leukemia. Med
Pediatr Oncol 2000;35:496-7.
17. Belianchikova NI, Veskova TK, Chimishkian KL,
Trubcheninova LP, Svet-Moldavskii GIa. Quantitative
changes in the cellular makeup of the spleen in mice
infected with the Rauscher leukemia virus and Brucella
abortus. Vopr Onkol 1979;25:76-80.
18. Doğanay M, Aygen B. Human brucellosis: an overview.
Int J Infect Dis 2003;7:173-82.
19. Kjeldsberg C, Johnson KE, Foucar K, Hussong J,
McKenna R, Perkins S, et al. Practical diagnosis of
Hematologic Disorders, 3rd ed. Chicago: ASCP press;
2000.
20. Flemming M, Kutok JL, Skarin AT. Examination of the
bone marrow. In: Handin RI, Lux SE, Stossel TP,
editors. Blood, Principles and Practices of Hematology.
Second edition, Philadelphia: Lippincot-Williams &
Wilkins; 2003. p.59-79.